For instance, anthracyclines and etoposide, two chemotherapeutic drugs used for AML treatment, enhance Fas- and TRAIL-R2-mediated cell death in vitro, a process requiring FADD molecule expression [40-42,44,45]. This evidence concerns the gene FAS and acute myeloid leukemia.